Selumetinib

  • Part D specialty tier in 80% of formularies (2026Q3)
  • KOSELUGO

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Selumetinib: storage and handling

Refrigerate
Yes, as the label states
Label statement
KOSELUGO Oral Granules Store and transport KOSELUGO oral granules refrigerated at 2°C to 8°C (36°F to 46°F).
Freezing
Not addressed
Room temperature
at or below 30°C (86°F)
Label statement
The capsules have a pink cap and white body where the cap is printed with “sel 7.5” in black ink, and body is printed with a sprinkle capsule image indicating opening. 60 0310‑0640‑60 Storage KOSELUGO Capsules Store KOSELUGO capsules at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
Room temperature
at or below 25°C (77°F)
Label statement
After receipt, patients may store at room temperature 20°C to 25°C (68°F to 77°F).
Room temperature
at or below 25°C (77°F)
Label statement
Store KOSELUGO oral granules at room temperature between 68°F to 77°F (20°C to 25°C). .
Room temperature
at or below 25°C (77°F)
Label statement
Store KOSELUGO capsules and KOSELUGO oral granules at room temperature between 68°F to 77°F (20°C to 25°C). .
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Dispense and store in the original bottle to protect from light and moisture.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 30°C (86°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

The capsules have a pink cap and white body where the cap is printed with “sel 7.5” in black ink, and body is printed with a sprinkle capsule image indicating opening. 60 0310‑0640‑60 Storage KOSELUGO Capsules Store KOSELUGO capsules at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-236-9933 (the number printed on the label) about this product.

Where the label prints this number
Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850 ©AstraZeneca 2025 For more information, go to website www.KOSELUGO.com or call 1-800-236-9933.
All storage statements on the label (12)
  • The capsules have a pink cap and white body where the cap is printed with “sel 7.5” in black ink, and body is printed with a sprinkle capsule image indicating opening. 60 0310‑0640‑60 Storage KOSELUGO Capsules Store KOSELUGO capsules at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].
  • Dispense and store in the original bottle to protect from light and moisture.
  • KOSELUGO Oral Granules Store and transport KOSELUGO oral granules refrigerated at 2°C to 8°C (36°F to 46°F).
  • After receipt, patients may store at room temperature 20°C to 25°C (68°F to 77°F).
  • Do NOT exceed 30°C (86°F).
  • Store KOSELUGO oral granules at room temperature between 68°F to 77°F (20°C to 25°C). .
  • Do not store KOSELUGO oral granules above 86°F (30°C).
  • Store KOSELUGO oral granules in the refrigerator between 36°F to 46°F (2°C to 8°C) if the temperature is above 86°F (30°C).
  • Keep KOSELUGO oral granules in its original bottle to protect from light and moisture.
  • How should I store KOSELUGO? .
  • Store KOSELUGO capsules and KOSELUGO oral granules at room temperature between 68°F to 77°F (20°C to 25°C). .
  • Keep KOSELUGO capsules and KOSELUGO oral granules in its original bottle to protect from light and moisture.

FDA label version 17, effective May 26, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
98%of those: prior authorization
0%step therapy
65%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.